Partnership for Research on Ebola VACcination (PREVAC)
- Conditions
- Ebola
- Registration Number
- PACTR201712002760250
- Lead Sponsor
- ational Institute of Allergy and Infectious Diseases (NIAID)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 2800
¿ Informed consent/assent
¿ Age greater than or equal to 1 year
¿ Planned residency in the area of the study site for the next 12 months
¿ Willingness to comply with the protocol requirements
¿ Fever > 38º Celsius
¿ History of EVD (self-report)
¿ Pregnancy (a negative urine pregnancy test is required for females of child-bearing potential, i.e., females who have experienced menarche or who are aged 14 years and older)
¿ Positive HIV test for participants < 18 years of age
¿ Reported current breast-feeding
¿ Prior vaccination against Ebola (self-report)
¿ Any vaccination in the past 28 days or planned within the 28 days after randomization (initial vaccination)
¿ In the judgement of the clinician, any clinically significant acute/chronic condition that would limit the ability of the participant to meet the requirements of the study protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method